Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-08
1996-02-06
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514383, A61K 3141
Patent
active
054895987
ABSTRACT:
5-Aryltriazol-3-thiones are useful for inhibiting adhesion of Mac-1 and thereby providing cytoprotection for diseases mediated by Mac-1 adhesion.
REFERENCES:
patent: 3514466 (1970-05-01), Stahle
patent: 3666771 (1972-05-01), Hoefle et al.
patent: 3962237 (1976-06-01), Boyle et al.
patent: 4230715 (1980-10-01), Albrecht et al.
patent: 4414221 (1983-11-01), Parsons et al.
patent: 4847276 (1989-07-01), Yarrington
patent: 4912095 (1990-03-01), Kane et al.
patent: 5100906 (1992-03-01), Miller
patent: 5143933 (1992-09-01), Kane et al.
Wallace et al., American Physiological Society, Rapid Communication, pp. G993-G998, 1993.
The Journal of Immunology, vol. 144, No. 7, Apr. 1990, Shappell et al., pp. 2702-2711.
Nature, vol. 349, Jan. 1991, Watson et al., pp. 164-167.
American Physiological Society, Rapid Communication, Wallace et al., pp. G993-G998 1993.
Circulation, vol. 81, No. 1, Jan. 1990, Simpson et al., pp. 226-237.
The Journal of Immunology, vol. 150, No. 6, Mar. 1993, Mulligan et al., pp. 2401-2406.
Gastroenterology, vol. 100, No. 4, 1991, Wallace et al., pp. 878-883.
Journal of Leukocyte Biology, vol. 48, 1990, Rosen, pp. 465-469.
Journal of Medicinal Chemistry, vol. 37, No. 1, 1994, Kane et al., pp. 125-132.
Journal of Medicinal Chemistry, vol. 33, No. 10, 1990, Kane et al., pp. 2772-2777.
Journal of Medicinal Chemistry, vol. 31, No. 6, 1988, Kane et al., pp. 1253-1258.
Journal of Medicinal Chemistry, vol. 13, No. 4, 1970, Mhasalkar et al., pp. 672-674.
Pharmazie, vol. 48, 1993, Rollas et al., pp. 308-309.
Journal of Pharmaceutical Sciences, vol. 58, No. 11, Nov. 1969, Shah et al., pp. 1398-1401.
Journal of Medicinal Chemistry, vol. 14, No. 3, 1971, Mhasalkar et al., pp. 260-262.
Journal of Medicinal Chemistry, vol. 27, No. 12, 1984, Maxwell et al., pp. 1565-1570.
J. Heterocyclic Chem. vol. 29, 1992, Sung et al., pp. 1101-1109.
Connor David T.
Plummer Janet S.
Ashbrook Charles W.
Crissey Todd M.
Dees Jos,e G.
Jones Dwayne C.
Warner-Lambert & Company
LandOfFree
Cytoprotection utilizing aryltriazol-3-thiones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytoprotection utilizing aryltriazol-3-thiones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytoprotection utilizing aryltriazol-3-thiones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175323